Macular edema is a condition in which the retinal layers around the fovea is accumulated by the fluid that leads to the vision impairment and also might lead to the vision loss. Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema. In addition to this, the macular degeneration is a condition in which the loss of vision occurs due to the retinal damage and it majorly affects adults (>50 years). Macular degeneration is a painless disease condition that leads to the loss of central vision. Macular degeneration is of two types, namely wet macular degeneration and dry macular degeneration. Growing aging population has increasingly become an issue that leads to the growing number of macular edema and degeneration case, contributing to the growth of the market. The therapies such as anti-vascular endothelial growth factor drugs for the treatment of diabetic macular edema and Lucentis (ranibizymab) & Avastin drugs for the macular degeneration have played a significant role in the growth of global macular edema and degeneration market.
Global macular edema and macular degeneration market is segmented based on the types of macular edema and macular degeneration. In addition to this, the Macular edema market is segmented based on its type, namely cystoid macular edema (CME) and diabetic macular edema (DME). Macular degeneration market is segmented based on its types such as dry age-related macular degeneration (Dry AMD) and wet age ‐related macular degeneration (wet AMD). The global macular edema and degeneration market is classified based on the treatment into macular edema diagnosis and macular degeneration diagnosis. Based on geography, the market is segmented into North America, Europe, Asia-pacific and LAMEA.
Companies such as Novartis, Roche, Bayer, Allergan, Ampio Pharmaceuticals and valeant Pharmaceuticals International are the leading players operating in the market. Leading players such as Bayer and Novartis are focusing on the joint venture strategy to develop new treatment option for the macular edema and macular degeneration.
Macular edema and degeneration market is segmented based on its types, treatment and geography.
MARKET BY TYPE
MARKET BY TREATMENT
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
Summary Adamis Pharmaceuticals Corporation (Adamis), formerly Cellegy Pharmaceuticals, Inc., is a specialty biopharmaceutical company that develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its lead pipeline product, Epinephrine Pre-filled Syringe (PFS) is developed for serious and common anaphylactic reactions such as foods, insect stings, medications and ...
October 2016 | $250 | View Details >>
DelveInsight’s, “ Ventricular Arrhythmia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Ventricular Arrhythmia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the ...
February 2017 | $1250 | View Details >>
The Global Resipiratory Drugs Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Resipiratory Drugs market. First, the report provides a basic overview of the Resipiratory Drugs industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed ...
June 2016 | $4000 | View Details >>
Notes: Sales, means the sales volume of Viral Inactivation Kits Revenue, means the sales value of Viral Inactivation Kits This report studies sales (consumption) of Viral Inactivation Kits in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and ...
November 2016 | $3900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research